Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses ANTX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ANTX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Eric Easom | $603,750 | $0 | $164,133 | $275,539 | $332,063 | $0 | $7,500 | $1,382,985 |
| President, Chief Executive Officer and Board Chair | ||||||||
| Josh Eizen | 450,000 | 0 | 66,105 | 110,975 | 180,000 | 0 | 0 | 807,080 |
| Chief Legal Officer and Chief Operating Officer | ||||||||
| Lucy Day | 447,200 | 0 | 52,545 | 88,211 | 178,880 | 0 | 7,500 | 774,336 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Eric Easom | $1,382,985 | — | — | — |
| Josh Eizen | 807,080 | — | — | — |
| Lucy Day | 774,336 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Eric Easom | RSU | 145,250 | — | $165,585 |
| Eric Easom | RSU | 74,250 | — | 84,645 |
| Josh Eizen | RSU | 58,500 | — | 66,690 |
| Lucy Day | RSU | 46,500 | — | 53,010 |
| Josh Eizen | RSU | 45,000 | — | 51,300 |
| Josh Eizen | RSU | 23,625 | — | 26,933 |
| Josh Eizen | RSU | 22,500 | — | 25,650 |
| Lucy Day | RSU | 20,625 | — | 23,513 |
| Eric Easom | Option | 14,063 | 17.28 | — |
| Eric Easom | Option | 72,489 | 11.99 | — |
| Eric Easom | Option | 103,125 | 3 | — |
| Eric Easom | Option | 223,928 | 1.13 | — |
| Josh Eizen | Option | 17,250 | 17.88 | — |
| Josh Eizen | Option | 13,583 | 14.29 | — |
| Josh Eizen | Option | 31,251 | 3 | — |
| Josh Eizen | Option | 45,938 | 1.08 | — |
| Josh Eizen | Option | 90,188 | 1.13 | — |
| Lucy Day | RSU | 36,578 | — | 0 |
| Lucy Day | RSU | 8,837 | — | 0 |
| Lucy Day | RSU | 22,588 | — | 0 |
| Lucy Day | Option | 4,125 | 17.28 | — |
| Lucy Day | Option | 22,290 | 14.29 | — |
| Lucy Day | Option | 28,646 | 3 | — |
| Lucy Day | Option | 71,677 | 1.13 | — |
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Margaret FitzPatrickIndependent · Lead Independent Director · Nominating and Corporate Governance · Compensation | $69,000 | $0 | $20,393 | — | — | $89,393 |
| Stephanie WongIndependent · Nominating and Corporate Governance · Audit (Chair) | 59,000 | 0 | 20,393 | — | — | 79,393 |
| Patricia MartinIndependent · Audit · Compensation | 51,250 | 597 | 20,393 | — | — | 72,240 |
| Joseph ZakrzewskiIndependent · Nominating and Corporate Governance · Audit | 51,500 | 0 | 20,393 | — | — | 71,893 |
| Rob Readnour, Ph.DIndependent · Nominating and Corporate Governance (Chair) | 48,000 | 0 | 20,393 | — | — | 68,393 |
| Melvin Spigelman, M.DIndependent · Compensation | 47,500 | 0 | 20,393 | — | — | 67,893 |
| Kabeer AzizIndependent · Audit · Compensation | 35,625 | 1,886 | 20,393 | — | — | 57,904 |
| Gilbert Lynn Marks, M.DIndependent · Nominating and Corporate Governance · Compensation | 35,625 | 1,886 | 20,393 | — | — | 57,904 |
| Eric EasomEmployee director · Board Chair | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $104,546 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 15,000 / 8,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $397,500 |
| Equity awards (grant-date value) | $4,369 |
| All other compensation | $0 |
| Total cost of the board | $401,869 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | AN2 Therapeutics | 2025 | Eric Easom | $603,750 | $164,133 | $275,539 | $332,063 | $1,382,985 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Eric Easom | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Executive Compensation”. As printed: 1,382,985. Filing ↗machine: r2 · c25 · span 352697–352706 |
| 2 | Section 01, Josh Eizen | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Executive Compensation”. As printed: 807,080. Filing ↗machine: r4 · c25 · span 372599–372606 |
| 3 | Section 01, Lucy Day | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Executive Compensation”. As printed: 774,336. Filing ↗machine: r6 · c25 · span 392493–392500 |
| 4 | Section 07, pay ratio | 10-K | 2026-03-17 | 0001193125-26-110693 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 5 | Section 08, Margaret FitzPatrick | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 89,393. Filing ↗machine: span 794030–794036 |
| 6 | Section 08, Stephanie Wong | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 79,393. Filing ↗machine: span 825272–825278 |
| 7 | Section 08, Patricia Martin | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 72,240. Filing ↗machine: span 806533–806539 |
| 8 | Section 08, Joseph Zakrzewski | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 71,893. Filing ↗machine: span 831517–831523 |
| 9 | Section 08, Rob Readnour, Ph.D | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 68,393. Filing ↗machine: span 812780–812786 |
| 10 | Section 08, Melvin Spigelman, M.D | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 67,893. Filing ↗machine: span 819030–819036 |
| 11 | Section 08, Kabeer Aziz | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 57,904. Filing ↗machine: span 787782–787788 |
| 12 | Section 08, Gilbert Lynn Marks, M.D | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 57,904. Filing ↗machine: span 800287–800293 |
| 13 | Section 08, Eric Easom | DEF 14A | 2026-04-22 | 0001193125-26-170314 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 14 | Section 09b board cost (computed) | Computed | — | computed | Cash 397,500 + equity 4,369 + all other 0 = 401,869, summed across the director compensation table rows.machine: formula: Σ = 401,869 |
| 15 | AN2 Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-22 | 0001193125-26-170314 | CEO total compensation as printed in AN2 Therapeutics's own proxy. As printed: 1,382,985. Filing ↗machine: r2 · c25 · span 352697–352706 |